51
Mosaic Skin Conditions
• A mosaic organism is composed of ≥2 genetically distinct cell populations derived from a homogeneous zygote.
– Genomic mosaicism results from alteration in the DNA sequence (affecting genes or chromosomes).
• Clinical findings in mosaic skin conditions depend not only on the underlying genetic alteration but also on the timing of its origin (with earlier onset generally leading to more widespread involvement) and the cells or tissues affected (cutaneous ± extracutaneous).
• The accessibility of the skin allows visualization of mosaic patterns.
– Blaschko’s lines are streaks and swirls that represent pathways of epidermal cell (e.g. keratinocyte or melanocyte) migration during embryonic development (Fig. 51.1).
• Types of cutaneous lesions that can follow Blaschko’s lines or have a block-like/segmental pattern are outlined in Tables 51.1 and 51.2, respectively (Fig. 51.2).
Table 51.1
Skin findings that can occur along Blaschko’s lines.
* Inflammatory manifestations occur primarily during infancy.
** In addition to conditions with inflammatory or verrucous papulonodules noted above.
GVHD, graft-versus-host disease; IP, incontinentia pigmenti; PEODDN, porokeratotic eccrine ostial and dermal duct nevus.
Table 51.2
Skin findings that can have a block-like or segmental pattern that reflects mosaicism.
Hypopigmentation – e.g. nevus depigmentosus, segmental vitiligo (see Chapter 54)
Hyperpigmention ± hypertrichosis – e.g. CALM, Becker’s nevus/smooth muscle hamartoma (see Table 50.3 and Chapter 55)
Hypertrichosis – e.g. X-linked congenital generalized hypertrichosis (female ‘carriers’)
Vascular lesions – e.g. port wine stain,† CMTC, unilateral nevoid telangiectasia, venous malformation,*